Pinned Tweet
#FDA... “law enforcement leader for #publichealth”. Have I got this right?
FDA Tracker retweeted
Protecting young people from the harms of tobacco use requires education, community engagement and policies that prioritize their health.
Advocate Shawna Watley calls on parents, educators and faith leaders to help young people understand the dangers of today’s tobacco products and urges continued investment in community education and youth tobacco prevention.
Read more: washingtoninformer.com/youth…
FDA Tracker retweeted
SCOOP: The CDC's deputy director is leaving.
Jennifer Shuford, an infectious-disease physician who had been Texas's health commissioner, was hired to help restore trust in CDC.
Now she's out after six months.
w @bylenasun
washingtonpost.com/politics/…
FDA Tracker retweeted
Scoop: ARPA-H Director Alicia Jackson is on administrative leave, following a Bloomberg Law inquiry into her ethics status.
news.bloomberglaw.com/health…
FDA Tracker retweeted
“We’ve got to make sure that that process is in place. We’re working really hard to do it,” Kyle Diamantas, acting FDA commissioner, said Monday about the agency's rare disease initiative framework. “It’s a top priority of mine.” news.bloomberglaw.com/health…
Of the 12 federal government agencies included in Gallup’s survey, the Postal Service (58%) and NASA (53%) receive the highest percentages of “excellent/good” ratings. The Food and Drug Administration (25%) and CDC (26%) receive the lowest.
Full story: on.gallup.com/4z2ZrJY
FDA Tracker retweeted
Oof.
ADA Admits Mistakes and Issues a Partial Apology - ConscienHealth conscienhealth.org/2026/10/2…
FDA Tracker retweeted
A watershed for FDA regulation. Every patient on the vaccine arm got a different product, with neoantigens chosen from sequencing of each person's own tumor. So FDA had no single active sequence to review. The IND pre-specified how the product would change for each patient.
#ESMO26 embargo lifted following breach.
Detailed data confirm Moderna $MRNA and Merck $MRK cancer vaccine met key endpoints in melanoma trial
Personalized mRNA therapy reduced disease recurrence by 42% compared to standard treatment
statnews.com/2026/10/22/esmo…












